NO20055002L - Benzol[1,2,5]tiadiazolforbindelser - Google Patents
Benzol[1,2,5]tiadiazolforbindelserInfo
- Publication number
- NO20055002L NO20055002L NO20055002A NO20055002A NO20055002L NO 20055002 L NO20055002 L NO 20055002L NO 20055002 A NO20055002 A NO 20055002A NO 20055002 A NO20055002 A NO 20055002A NO 20055002 L NO20055002 L NO 20055002L
- Authority
- NO
- Norway
- Prior art keywords
- benzo
- thiadiazole
- cck2
- amidophenylsulfanylamino
- treatment
- Prior art date
Links
- PDQRQJVPEFGVRK-UHFFFAOYSA-N 2,1,3-benzothiadiazole Chemical compound C1=CC=CC2=NSN=C21 PDQRQJVPEFGVRK-UHFFFAOYSA-N 0.000 title abstract 2
- ARLKVQYMFRECLV-JSGCOSHPSA-N (2s)-2-[[(2s)-2-amino-3-(1h-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanamide Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCSC)C(N)=O)=CNC2=C1 ARLKVQYMFRECLV-JSGCOSHPSA-N 0.000 abstract 2
- 108091005932 CCKBR Proteins 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45863803P | 2003-03-28 | 2003-03-28 | |
| PCT/US2004/009589 WO2005012275A2 (en) | 2003-03-28 | 2004-03-26 | Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055002D0 NO20055002D0 (no) | 2005-10-27 |
| NO20055002L true NO20055002L (no) | 2005-12-14 |
Family
ID=34115280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055002A NO20055002L (no) | 2003-03-28 | 2005-10-27 | Benzol[1,2,5]tiadiazolforbindelser |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7241759B2 (es) |
| EP (1) | EP1675837A2 (es) |
| JP (1) | JP2006528241A (es) |
| KR (1) | KR20050119666A (es) |
| CN (1) | CN1829704A (es) |
| AU (1) | AU2004261547A1 (es) |
| BR (1) | BRPI0408899A (es) |
| CA (1) | CA2520546A1 (es) |
| CO (1) | CO5700819A2 (es) |
| CR (1) | CR8009A (es) |
| EC (1) | ECSP056057A (es) |
| IS (1) | IS8042A (es) |
| MX (1) | MXPA05010484A (es) |
| NO (1) | NO20055002L (es) |
| NZ (1) | NZ542491A (es) |
| RS (1) | RS20050733A (es) |
| RU (1) | RU2005133206A (es) |
| UA (1) | UA82872C2 (es) |
| WO (1) | WO2005012275A2 (es) |
| ZA (1) | ZA200508732B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005085188A2 (en) * | 2004-03-02 | 2005-09-15 | Compass Pharmaceuticals Llc | Compounds and methods for anti-tumor therapy |
| US7297816B2 (en) | 2004-09-24 | 2007-11-20 | Janssen Pharmaceutica N.V. | Sulfonamide compounds |
| US7599588B2 (en) * | 2005-11-22 | 2009-10-06 | Vascular Imaging Corporation | Optical imaging probe connector |
| EP1795198A1 (en) * | 2005-12-09 | 2007-06-13 | Hubrecht Laboratorium | Treatment of Barret's esophagus |
| WO2008124518A1 (en) * | 2007-04-03 | 2008-10-16 | Janssen Pharmaceutica N.V. | Oxo-dihydroisoindole sulfonamide compounds as modulators of the cck2 receptor |
| EP2053052A1 (en) * | 2007-10-23 | 2009-04-29 | Laboratorios del Dr. Esteve S.A. | Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide |
| PE20120693A1 (es) | 2009-06-29 | 2012-07-04 | Agios Pharmaceuticals Inc | Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2) |
| RU2532492C1 (ru) * | 2013-01-28 | 2014-11-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации | Способ эндоскопического лечения гастродуоденальных язв |
| RU2693484C1 (ru) | 2013-11-22 | 2019-07-03 | СиЭль БАЙОСАЕНСИЗ ЭлЭлСи | Антагонисты гастрина для лечения и профилактики остеопороза |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2703995B1 (fr) | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant. |
| JP3999819B2 (ja) | 1996-12-10 | 2007-10-31 | ゼリア新薬工業株式会社 | １，５―ベンゾジアセピン誘導体 |
| WO2000078145A1 (en) * | 1999-06-24 | 2000-12-28 | Smithkline Beecham Corporation | Macrophage scavenger receptor antagonists |
| GB0028702D0 (en) | 2000-11-24 | 2001-01-10 | Novartis Ag | Organic compounds |
| JP2004529170A (ja) * | 2001-05-07 | 2004-09-24 | スミスクライン・ビーチャム・コーポレイション | スルホンアミド |
| ITTO20020674A1 (it) | 2002-07-26 | 2004-01-26 | Rotta Research Lab | Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico |
-
2004
- 2004-03-26 MX MXPA05010484A patent/MXPA05010484A/es unknown
- 2004-03-26 BR BRPI0408899-9A patent/BRPI0408899A/pt not_active IP Right Cessation
- 2004-03-26 EP EP04785868A patent/EP1675837A2/en not_active Withdrawn
- 2004-03-26 KR KR1020057018397A patent/KR20050119666A/ko not_active Withdrawn
- 2004-03-26 JP JP2006532352A patent/JP2006528241A/ja not_active Withdrawn
- 2004-03-26 CN CNA2004800144708A patent/CN1829704A/zh active Pending
- 2004-03-26 WO PCT/US2004/009589 patent/WO2005012275A2/en not_active Ceased
- 2004-03-26 NZ NZ542491A patent/NZ542491A/en unknown
- 2004-03-26 RU RU2005133206/04A patent/RU2005133206A/ru not_active Application Discontinuation
- 2004-03-26 UA UAA200509353A patent/UA82872C2/uk unknown
- 2004-03-26 AU AU2004261547A patent/AU2004261547A1/en not_active Abandoned
- 2004-03-26 RS YUP-2005/0733A patent/RS20050733A/sr unknown
- 2004-03-26 US US10/811,292 patent/US7241759B2/en not_active Expired - Lifetime
- 2004-03-26 CA CA002520546A patent/CA2520546A1/en not_active Abandoned
-
2005
- 2005-09-23 IS IS8042A patent/IS8042A/is unknown
- 2005-09-28 EC EC2005006057A patent/ECSP056057A/es unknown
- 2005-09-28 CR CR8009A patent/CR8009A/es unknown
- 2005-10-05 CO CO05100979A patent/CO5700819A2/es not_active Application Discontinuation
- 2005-10-27 ZA ZA200508732A patent/ZA200508732B/en unknown
- 2005-10-27 NO NO20055002A patent/NO20055002L/no not_active Application Discontinuation
-
2007
- 2007-07-10 US US11/775,535 patent/US7550492B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CR8009A (es) | 2008-09-10 |
| US20070276016A1 (en) | 2007-11-29 |
| US7550492B2 (en) | 2009-06-23 |
| CO5700819A2 (es) | 2006-11-30 |
| MXPA05010484A (es) | 2006-03-10 |
| WO2005012275A3 (en) | 2006-05-11 |
| CA2520546A1 (en) | 2005-02-10 |
| CN1829704A (zh) | 2006-09-06 |
| NO20055002D0 (no) | 2005-10-27 |
| NZ542491A (en) | 2009-04-30 |
| KR20050119666A (ko) | 2005-12-21 |
| ZA200508732B (en) | 2007-04-25 |
| BRPI0408899A (pt) | 2006-04-18 |
| RU2005133206A (ru) | 2006-05-10 |
| UA82872C2 (en) | 2008-05-26 |
| US7241759B2 (en) | 2007-07-10 |
| ECSP056057A (es) | 2006-01-27 |
| US20040224983A1 (en) | 2004-11-11 |
| RS20050733A (sr) | 2007-06-04 |
| EP1675837A2 (en) | 2006-07-05 |
| IS8042A (is) | 2005-09-23 |
| JP2006528241A (ja) | 2006-12-14 |
| AU2004261547A1 (en) | 2005-02-10 |
| WO2005012275A2 (en) | 2005-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20061122L (no) | 2-(Quinoksalin-5-ylsuflonylamino)-benzamid forbindelser som CCK2 modulatorer | |
| WO2004098494A3 (en) | Compounds, compositions, and methods | |
| NO20072092L (no) | Sulfonamidforbindelser | |
| DK1206474T3 (da) | Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer | |
| SG10201809390QA (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
| YU17402A (sh) | Nova spiroheterociklična jedinjenja upotrebljiva kao reverzibilni inhibitori cisteinskih proteaza | |
| ATE417051T1 (de) | Polymorphe von clopidogrel-hydrogensulfat | |
| WO2006005609A3 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
| NO20055130L (no) | Aminocykloheksyleter-forbindelser og deres anvendelse | |
| CA2474510A1 (en) | Fused tricyclic heterocycles useful for treating hyper-proliferative disorders | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| NO20031648D0 (no) | Farmasöytiske lösninger av modafinilforbindelser | |
| WO2005035537A3 (en) | Substituted tricyclic heterocycles and their uses | |
| WO2002010152A3 (de) | Neue indolderivate und deren verwendung als arzneimittel | |
| DE602004006118D1 (de) | 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER | |
| DE60316128D1 (de) | N-sulfonylurea-apoptosis-förderer | |
| NO20032406L (no) | Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens | |
| WO2005012275A3 (en) | Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators | |
| WO2005061496A8 (en) | Aminopyridine-derivatives as inductible no-synthase inhibitors | |
| TW200510323A (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
| WO2005117543A3 (en) | N-sulfonylcarboximidamide apoptosis promoters | |
| DE602006002608D1 (de) | 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
| DK1368023T3 (da) | Anvendelse af buprenoprphin til behandling af urininkontinens | |
| EP1436279B8 (en) | Chemical compounds | |
| AU2003266093A1 (en) | Cyclooct-(en-)yl derivatives for use as fragrances |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |